Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports

Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports

Abstract Background Permanent neonatal diabetes mellitus (PNDM) presents with dehydration and hyperglycemia, which usually occurs during the first 12 months of life. Activating mutations of beta-cell adenosine triphosphate-sensitive potassium [KATP] channel subunits that cause opening of the channel...

Full description

Bibliographic Details
Main Authors: Maryam Razzaghy-Azar, Mitra Nourbakhsh, Ali Talea, Mahsa Mohammad Amoli, Mona Nourbakhsh, Bagher Larijani
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Journal of Medical Case Reports
Subjects:
Permanent
Neonatal
Diabetes mellitus
Repaglinide
Case report
Online Access:https://doi.org/10.1186/s13256-021-03052-5

Internet

https://doi.org/10.1186/s13256-021-03052-5

Similar Items